Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.

CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief ...

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

Piramal Pharma Limited has achieved an environmental milestone at its API and intermediates manufacturing facility in Digwal, ...

BioMed X, an independent biomedical research institute based in Germany, has launched a new collaboration with Daiichi Sankyo ...